Page last updated: 2024-09-03

n-(2-isobutyl-3-(n'-hydroxycarbonylamido)propanoyl)-o-methyltyrosinemethylamide and Ulcer

n-(2-isobutyl-3-(n'-hydroxycarbonylamido)propanoyl)-o-methyltyrosinemethylamide has been researched along with Ulcer in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dickinson, RP; Fray, MJ; Huggins, JP; Occleston, NL1

Other Studies

1 other study(ies) available for n-(2-isobutyl-3-(n'-hydroxycarbonylamido)propanoyl)-o-methyltyrosinemethylamide and Ulcer

ArticleYear
A potent, selective inhibitor of matrix metalloproteinase-3 for the topical treatment of chronic dermal ulcers.
    Journal of medicinal chemistry, 2003, Jul-31, Volume: 46, Issue:16

    Topics: Administration, Cutaneous; Animals; Caproates; Cell Movement; Cells, Cultured; Chronic Disease; Fibronectins; Gelatin; Humans; Keratinocytes; Male; Matrix Metalloproteinase 3; Matrix Metalloproteinase Inhibitors; Polycyclic Compounds; Protease Inhibitors; Rabbits; Skin; Skin Diseases; Stereoisomerism; Structure-Activity Relationship; Ulcer; Valine

2003